• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL’s CEO will open the upcoming RDAF workshop on market access

On 26 April 2022, SFL’s CEO Shayesteh Fürst-Ladani will open the virtual multi-stakeholder workshop on ‘Market access for orphan drugs in Switzerland’ organized by the Rare Disease Action Forum (RDAF).

On the basis of a fictional case study, participants in the workshop will be given the opportunity to engage in discussions on the current framework for market access in Switzerland as well as to identify potential areas for improvement and solutions in a multi-stakeholder approach. This workshop aims to gather stakeholders from across the field of rare diseases: patient organizations, industry, research organizations, healthcare professionals, public authorities, decision makers and insurers.

Registration for the workshop is open.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top